Aug 13, 2024
SITC Announces Fireside Chat with Dr. Kim Rathmell and Dr. Leisha Emens at its 39th Annual Meeting
Aug 05, 2024
SITC Announces 2024 Class of Fellows to the Academy of Immuno-Oncology
May 15, 2024
SITC Announces Keynote Speakers Dr. Rafi Ahmed and Dr. Elizabeth M. Jaffee at its 39th Annual Meeting
Apr 23, 2024
Society for Immunotherapy of Cancer Publishes Recommendations on Optimal Intratumoral Immunotherapy Clinical Trial (IICT) Design
Apr 12, 2024
SITC and the NCI Announce Fourth Year of Collaboration with the New AI in IO: Computational Immuno-oncology Webinar Series
Nov 09, 2020
Amphivena Presents Clinical Update and Translational Data of AMV564 in Solid Tumor Patients at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Aug 10, 2020
Society for Immunotherapy of Cancer Offers Certificate in Cancer Immunotherapy for Physicians and Qualified Healthcare Providers
Jun 03, 2020
Online Video Education Series from SITC and PlatformQ Health to Better Equip HCPs Managing Cancer Patients Undergoing Immunotherapy
Jun 01, 2020
Society for Immunotherapy of Cancer Celebrates Cancer Immunotherapy Month(TM)
Apr 23, 2020
SITC Announces Three Recipients of the 2020 Richard V. Smalley, MD, Memorial Award and Lectureship
Mar 25, 2020
Society for Immunotherapy of Cancer Advocates for Expanded Access to Anti-IL-6 Therapies for Critically Ill Patients
Dec 20, 2019
Society for Immunotherapy of Cancer Updates its Clinical Immunotherapy Treatment Guidelines for Advanced Renal Cell Carcinoma
Dec 18, 2019
Society for Immunotherapy of Cancer to Host Unique 2-Day Workshop Focused on Interrogating the Tumor-Specific Surfaceome for Immune Targeting
Nov 12, 2019
OncoSec Presents Immunological Data Associated with Positive Tumor Response from TAVO(TM) KEYNOTE Studies Evaluating Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
Nov 11, 2019
Presentation of ONCOS-102 Melanoma Data at SITC Annual Meeting
Nov 09, 2019
Nektar Therapeutics Presents New Clinical and Preclinical Data from its Immuno-Oncology Pipeline at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 08, 2019
Brain Cancer Patient Survival, Immune and Tumor Data from AIVITA Biomedical's Phase 2 Clinical Trial to be Presented at SITC Annual Meeting
Nov 08, 2019
Tocagen Highlights Toca 6 Phase 1b Data at Society for Immunotherapy of Cancer Annual Meeting
Nov 06, 2019
Alligator Bioscience: ATOR-1017 Induces Long-Lasting Immunity - New Preclinical Data to be Presented at SITC 34th Annual Meeting
Nov 05, 2019
Cutting-Edge Research Anticipated at Society for Immunotherapy of Cancer's 34th Annual Meeting